AlphAIAlphAI — Financial news for AI agents
247wallst.comOCT 312 min read$LRCX

Jim Cramer Likes Lam Research but Says Buy Just 25% of Your Position

Jim Cramer recommended Lam Research (LRCX) as a top capital equipment stock but advised buying only 25% of a desired position. The stock fell 6.38% to $238.15, down 26.47% from a month high. Lam's Q3 revenue rose 54.4% to $8.22B, beating estimates, with EPS at $2.20. The company guided Q4 revenue to $8.60B and EPS to $2.33. Risks include China exposure, export controls, and supply constraints.

Original reporting
247wallst.com
Published Oct 31, 2026, 10:17 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 31, 2026, 10:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Jim Cramer Likes Lam Research but Says Buy Just 25% of Your Position — source image
Source · 247wallst.com
Decision brief

The 30-second read

$LRCXNeutralLow
01

Why it matters

The commentary adds a modest bearish tilt to an otherwise bullish earnings backdrop.

02

Market read

Recap of already‑public earnings with a cautious analyst note; limited new trading impetus.

03

What to watch

China revenue exposure and export‑control risks remain material but are already priced in.

Relevance 4/10Novelty 2/10Timing: none

Background

Jim Cramer praised Lam Research as "best in the game" but advised buying only a quarter of a desired position, following a recent earnings beat and guidance release.

Company-level read

Ticker impact

$LRCXNeutralMedium confidence
Context

Recaps Q3 earnings and guidance already released on 2026-10-21; no new corporate event.

Expected impact

likely pressure as investors digest the cautious stance despite solid results

Evidence & confidence

The earnings numbers are already public, but the advisory to buy only 25% of a position adds a modest downside bias.

Market effects

Sector

Semiconductor equipment sector may see modest caution as analysts temper buying enthusiasm.

Regional

U.S. markets only; no regional ripple.

Global

Limited to investors tracking chip‑equipment stocks.

Counterpoint

What could challenge this read

Despite the cautious buy‑limit, the strong earnings beat could support a short‑term rally.

Key entities

  • company
    Lam Research

    Semiconductor equipment maker (ticker LRCX).

  • person
    Jim Cramer

    CNBC host providing the recommendation.

Read at source← All news

Related articles

OCT 30
$INTCMed

Semiconductor Stocks Fall as Intel Earnings Trigger Broad Tech Selloff

Semiconductor stocks fell after Intel's earnings miss and weak outlook, along with Amazon's earnings shortfall, sparking concerns about AI spending. Intel's stock dropped 25%, erasing $120B in market cap. Broadcom, AMD, Micron, Applied Materials, and Lam Research also declined. Qualcomm fell due to broader tech selloff. Alphabet and Amazon also reported revenue misses, while Meta plans $95B in stock offerings for AI investments.

morningstar.com6 min
OCT 28
$LRCXHigh

Chip Equipment Stocks Rally as SK Hynix Signals Memory Shortage Into 2030: Lam Research Jumps 5%, Applied Materials Climbs 4%, KLA Gains 3%

SK Hynix (SKHY) predicts a memory shortage until 2030, driving gains in chip equipment stocks. Lam Research (LRCX) rose 5%, Applied Materials (AMAT) 4%, and KLA (KLAC) 3%. SK Hynix's outlook suggests increased demand for fab equipment. Lam Research faces supply constraints, forecasting $8.6B in Q4 revenue. Applied Materials and KLA also reported growth. ASML (ASML) gained 1%.

247wallst.com3 min
OCT 28
$LRCXHighAI 8/10

Why is Lam Research stock rallying today?

Lam Research (LRCX) stock rose 3.4% after SK Hynix reported record Q3 2026 revenue and strong demand for memory chips. Analyst Lynx Equity reiterated a $400 price target, citing robust sector demand and potential share buybacks. The rally was driven by company-specific factors, not broader market trends.

investing.com1 min
OCT 27
$LRCXMed

Lam Research Stock Is 45% Below Its High. How Deep Have Past Drops Gone?

Lam Research (LRCX) shares have fallen 45.1% from their June 30 high, despite reporting record revenue. Historically, the stock has declined more than the S&P 500 during market shocks, with an average drop of 22.8%. The company's operating margin is at a 40-quarter high, and it holds $7.44 billion in cash. Management cited supply chain constraints for a cautious revenue forecast.

finance.yahoo.com3 min
OCT 27
$LRCXMedAI 8/10

Tech Sell-Off: This All-Star Artificial Intelligence Stock Is Down 50% but Up 127,300% Since Its IPO. Here's Why It's a Screaming Buy Heading Into the Midterms.

Lam Research (LRCX) stock is down 50% from its June high but up 127,300% since its 1984 IPO. The semiconductor equipment maker reported record Q3 revenue of $8.22B and EPS of $2.20, beating estimates. Despite strong results, the stock fell due to 'light' guidance of $8.6B revenue and $2.33 EPS for Q4, attributed to supply constraints. Management forecasts industrywide wafer front-end equipment spending to exceed $200B by 2027, with Lam expected to grow faster than the industry.

finance.yahoo.com3 min
OCT 26
$LRCXMed

Lam Research Stocks Gain 4.3% Despite Citi's Target Cut

Lam Research (LRCX) shares rose 4.3% to $239.93 on October 26, despite Citi cutting its price target while maintaining a Buy rating. The company projected December-quarter revenue of $8.6 billion, with a 40.2% adjusted operating margin in September. Investors will watch for earnings growth to meet expectations.

finance.yahoo.com2 min